Literature DB >> 9224746

Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.

K Washington1, P A Clavien, P Killenberg.   

Abstract

The peribiliary vascular plexus plays an important role in physiology of bile flow. Disturbance of the microcirculation may contribute to ductal injury, but little is known about alterations in the vascular supply of small bile ducts in liver disease. Immunoperoxidase stains for vascular endothelium (Ulex europaeus, factor VIII-related antigen, CD34) were used to study the peribiliary vascular plexus in 20 cases of primary sclerosing cholangitis (PSC) and 27 cases of primary biliary cirrhosis (PBC), two diseases characterized by bile duct destruction. Normal liver from 10 autopsy cases of sudden cardiac death was used as a control. Interlobular bile ducts (20- to 80-microm diameter) were identified on AE1/AE3 immunostain; vessels adjacent to the basement membrane of these ducts were counted. Normal interlobular bile ducts had an average of 2.15 vessels per duct (range, 1.68 to 2.71). Few PBC or PSC cases had a normal number of peribiliary vessels. There was a trend toward vasopenia at higher stage, although vascular loss was noted in early stages as well. The pattern of vascular loss was different for the two diseases; in PSC, the periductal capillaries were often preserved but were pushed away from the basement membrane by concentric deposits of collagen. Small residual vessels could be identified within fibrous scars of obliterated bile ducts in PSC. In 4 stage 3 or 4 PSC cases with little bile duct injury, vessel/duct ratio approached normal levels. In PBC, vessels were obliterated in areas of granulomatous inflammation and heavy lymphocytic infiltrate around bile ducts. In conclusion, loss of peribiliary vessels is common in PSC and PBC. Vessel loss is seen in early stages and may contribute an element of ischemia to continued small bile duct loss but is probably secondary to the inflammatory process.

Entities:  

Mesh:

Year:  1997        PMID: 9224746     DOI: 10.1016/s0046-8177(97)90151-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

Review 1.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Angiogenesis and proliferation of bile duct enhances ischemic tolerance in rats with cirrhosis.

Authors:  Zhiqiang Zhang; Zhennan Li; Chen Zou; Jingjing Zhang; Yi Zhu; Yi Miao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis.

Authors:  James H Tabibian; Christy E Trussoni; Steven P O'Hara; Patrick L Splinter; Julie K Heimbach; Nicholas F LaRusso
Journal:  Lab Invest       Date:  2014-07-21       Impact factor: 5.662

4.  Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling.

Authors:  Lindsey Kennedy; Vik Meadows; Jennifer Demieville; Laura Hargrove; Shohaib Virani; Shannon Glaser; Tianhao Zhou; Evan Rinehart; Victoria Jaeger; Konstantina Kyritsi; Linh Pham; Gianfranco Alpini; Heather Francis
Journal:  Lab Invest       Date:  2020-02-13       Impact factor: 5.662

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.